Nifty
:
17853.20
Sensex
:
60048.47
30.25 (0.17%)
163.11 (0.27%)
Nifty
Sensex
:
:
17853.20
60048.47
30.25 (0.17%)
163.11 (0.27%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
67/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
1019.25
24-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  1049.95
  •  1049.95
  •  1005.00
  •  1023.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2156
  •  22.13
  •  1197.00
  •  276.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 929.15
  • 26.02
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 989.68
  • 0.43%
  • 4.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.22%
  • 4.13%
  • 22.99%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.87
  • 1.26
  • 7.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.86
  • 85.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.17
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.63
  • 23.81
  • 13.88

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.66
  • 2.69
  • 2.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.54
  • 20.71
  • 24.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
112.50
48.49
132.01%
61.77
46.15
33.85%
65.52
53.78
21.83%
54.89
50.32
9.08%
Expenses
72.03
36.19
99.03%
49.52
32.77
51.11%
50.27
44.45
13.09%
45.19
44.89
0.67%
EBITDA
40.47
12.30
229.02%
12.25
13.39
-8.51%
15.25
9.33
63.45%
9.70
5.43
78.64%
EBIDTM
35.97%
25.36%
19.83%
29.00%
23.28%
17.35%
17.67%
10.79%
Other Income
0.35
0.36
-2.78%
0.88
0.38
131.58%
0.25
2.91
-91.41%
2.13
0.08
2,562.50%
Interest
2.67
3.00
-11.00%
3.09
3.41
-9.38%
2.92
2.96
-1.35%
3.71
3.30
12.42%
Depreciation
2.35
2.04
15.20%
2.38
2.07
14.98%
2.09
2.07
0.97%
2.04
2.06
-0.97%
PBT
35.80
7.62
369.82%
7.66
8.29
-7.60%
10.49
7.22
45.29%
6.08
0.14
4,242.86%
Tax
9.07
1.98
358.08%
1.21
3.09
-60.84%
2.02
-0.31
-
0.42
-0.49
-
PAT
26.73
5.64
373.94%
6.46
5.19
24.47%
8.47
7.53
12.48%
5.66
0.63
798.41%
PATM
23.76%
11.63%
10.46%
11.25%
12.92%
14.00%
10.31%
1.25%
EPS
33.93
8.44
302.01%
8.76
7.92
10.61%
12.80
11.62
10.15%
8.85
1.83
383.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
294.68
230.67
201.59
183.75
209.50
216.66
232.43
201.88
195.07
173.51
157.72
Net Sales Growth
48.27%
14.43%
9.71%
-12.29%
-3.30%
-6.78%
15.13%
3.49%
12.43%
10.01%
 
Cost Of Goods Sold
103.16
67.35
51.97
58.82
57.75
55.66
71.38
79.51
76.68
74.95
94.19
Gross Profit
191.52
163.33
149.62
124.94
151.75
160.99
161.06
122.37
118.39
98.56
63.52
GP Margin
64.99%
70.81%
74.22%
67.99%
72.43%
74.31%
69.29%
60.62%
60.69%
56.80%
40.27%
Total Expenditure
217.01
181.18
165.93
181.48
184.98
184.29
194.28
183.91
171.01
156.71
170.56
Power & Fuel Cost
-
11.32
11.49
9.70
8.41
9.77
10.83
8.36
10.04
10.03
10.27
% Of Sales
-
4.91%
5.70%
5.28%
4.01%
4.51%
4.66%
4.14%
5.15%
5.78%
6.51%
Employee Cost
-
39.99
44.28
45.69
44.65
40.00
36.30
32.64
31.14
27.27
23.70
% Of Sales
-
17.34%
21.97%
24.87%
21.31%
18.46%
15.62%
16.17%
15.96%
15.72%
15.03%
Manufacturing Exp.
-
21.41
24.01
22.45
27.46
31.30
31.28
21.69
16.38
11.80
12.36
% Of Sales
-
9.28%
11.91%
12.22%
13.11%
14.45%
13.46%
10.74%
8.40%
6.80%
7.84%
General & Admin Exp.
-
12.03
14.05
17.57
18.93
18.86
14.75
13.52
11.72
11.33
9.75
% Of Sales
-
5.22%
6.97%
9.56%
9.04%
8.70%
6.35%
6.70%
6.01%
6.53%
6.18%
Selling & Distn. Exp.
-
14.92
12.28
17.71
18.27
16.70
12.05
10.87
10.06
7.65
5.89
% Of Sales
-
6.47%
6.09%
9.64%
8.72%
7.71%
5.18%
5.38%
5.16%
4.41%
3.73%
Miscellaneous Exp.
-
14.16
7.86
9.54
9.51
11.99
17.69
17.32
14.98
13.68
5.89
% Of Sales
-
6.14%
3.90%
5.19%
4.54%
5.53%
7.61%
8.58%
7.68%
7.88%
9.13%
EBITDA
77.67
49.49
35.66
2.27
24.52
32.37
38.15
17.97
24.06
16.80
-12.84
EBITDA Margin
26.36%
21.45%
17.69%
1.24%
11.70%
14.94%
16.41%
8.90%
12.33%
9.68%
-8.14%
Other Income
3.61
3.62
3.46
2.67
3.49
3.32
3.19
12.59
4.90
3.34
2.94
Interest
12.39
12.71
12.88
11.82
11.87
11.84
12.33
14.53
15.63
15.28
13.55
Depreciation
8.86
8.55
8.27
7.99
7.42
7.47
11.89
11.49
9.36
8.91
7.67
PBT
60.03
31.86
17.97
-14.87
8.74
16.37
17.13
4.54
3.98
-4.05
-31.12
Tax
12.72
5.63
2.09
-1.84
0.10
1.60
1.91
-0.89
1.28
2.27
1.35
Tax Rate
21.19%
17.67%
11.63%
12.37%
1.14%
9.77%
11.15%
-19.60%
32.16%
-56.05%
-4.34%
PAT
47.32
26.23
15.88
-13.01
8.70
14.77
15.22
5.44
2.70
-6.32
-32.47
PAT before Minority Interest
47.32
26.23
15.88
-13.03
8.64
14.77
15.22
5.44
2.70
-6.32
-32.47
Minority Interest
0.00
0.00
0.00
0.02
0.06
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
16.06%
11.37%
7.88%
-7.08%
4.15%
6.82%
6.55%
2.69%
1.38%
-3.64%
-20.59%
PAT Growth
149.18%
65.18%
-
-
-41.10%
-2.96%
179.78%
101.48%
-
-
 
EPS
51.43
28.51
17.26
-14.14
9.46
16.05
16.54
5.91
2.93
-6.87
-35.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
183.02
158.09
168.91
152.44
74.03
59.20
56.53
52.17
58.52
91.56
Share Capital
9.19
9.18
9.18
9.04
8.52
8.47
8.45
8.05
8.05
8.05
Total Reserves
173.35
148.31
159.18
141.36
65.51
50.73
48.08
43.27
50.47
83.51
Non-Current Liabilities
7.51
2.71
6.72
7.60
70.83
82.04
89.97
99.37
71.58
67.61
Secured Loans
0.09
0.14
0.01
0.47
15.89
18.83
24.47
32.08
2.78
0.06
Unsecured Loans
11.76
9.21
11.48
11.93
47.52
55.81
52.30
59.72
62.13
60.83
Long Term Provisions
0.00
0.00
0.00
0.00
0.54
0.49
0.46
0.39
0.30
1.24
Current Liabilities
154.81
146.69
124.94
124.17
129.66
135.61
137.09
120.36
150.31
134.08
Trade Payables
29.68
35.04
30.55
31.63
34.90
60.15
56.97
51.65
59.03
64.17
Other Current Liabilities
46.86
43.72
29.76
38.13
37.04
16.51
23.68
14.81
12.93
10.60
Short Term Borrowings
76.61
66.86
63.73
53.45
51.88
53.78
52.74
50.55
75.35
54.15
Short Term Provisions
1.66
1.07
0.90
0.95
5.83
5.17
3.71
3.34
3.00
5.16
Total Liabilities
345.34
307.47
300.51
284.21
274.52
276.85
283.59
271.90
280.41
293.25
Net Block
116.31
123.41
125.90
123.71
117.35
122.32
121.26
123.66
133.75
118.75
Gross Block
147.14
146.06
140.78
131.17
212.16
206.19
192.01
185.14
187.89
165.44
Accumulated Depreciation
30.83
22.66
14.87
7.46
94.80
83.87
70.75
61.47
54.14
46.69
Non Current Assets
164.85
157.61
157.47
159.81
141.68
143.38
149.17
148.01
151.01
149.69
Capital Work in Progress
7.54
2.45
2.47
8.95
5.79
3.50
11.63
10.70
6.77
16.89
Non Current Investment
35.47
26.64
24.38
21.83
5.64
4.59
3.59
3.59
0.51
0.51
Long Term Loans & Adv.
2.91
2.67
2.39
3.01
12.19
12.70
12.11
9.79
9.54
12.02
Other Non Current Assets
2.62
2.45
2.33
2.30
0.70
0.28
0.58
0.27
0.45
1.52
Current Assets
180.49
149.86
143.04
124.40
132.83
133.47
134.44
123.89
129.40
143.57
Current Investments
0.00
0.00
0.00
1.05
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
54.61
53.63
49.58
48.44
58.26
62.30
66.34
54.70
47.23
46.26
Sundry Debtors
102.48
72.91
68.63
48.25
47.57
45.56
39.58
32.35
48.13
66.57
Cash & Bank
5.29
3.45
6.91
8.62
14.30
8.70
6.57
12.21
6.70
6.18
Other Current Assets
18.11
5.42
5.34
5.32
12.70
16.92
21.94
24.63
27.35
24.55
Short Term Loans & Adv.
12.28
14.45
12.57
12.72
11.34
15.58
20.57
23.22
26.34
22.62
Net Current Assets
25.68
3.18
18.09
0.23
3.18
-2.14
-2.66
3.53
-20.92
9.49
Total Assets
345.34
307.47
300.51
284.21
274.51
276.85
283.61
271.90
280.41
293.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
0.33
10.92
7.86
-1.51
25.76
19.09
8.35
4.45
-14.33
4.49
PBT
26.87
-12.60
11.33
17.56
30.52
19.85
19.61
11.23
-17.57
20.55
Adjustment
9.33
16.74
14.93
15.92
10.05
10.48
8.47
7.72
6.80
6.26
Changes in Working Capital
-35.63
7.08
-19.05
-35.16
-0.57
2.40
-2.82
3.04
11.34
-11.62
Cash after chg. in Working capital
0.57
11.22
7.21
-1.67
40.00
32.73
25.26
22.00
0.57
15.19
Interest Paid
0.00
0.00
0.00
0.00
-12.33
-14.53
0.00
0.00
0.00
0.00
Tax Paid
-0.24
-0.30
0.65
0.16
-1.91
0.89
-1.28
-2.27
-1.35
-0.40
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.47
-3.72
-0.04
-4.14
-7.17
-6.27
-6.71
-4.56
-11.76
-9.17
Net Fixed Assets
-6.16
-5.34
-3.11
20.82
-6.64
-2.13
-3.68
2.13
-7.75
-11.11
Net Investments
0.06
-0.01
1.01
-1.33
0.01
-0.23
0.00
-3.09
-0.01
0.00
Others
0.63
1.63
2.06
-23.63
-0.54
-3.91
-3.03
-3.60
-4.00
1.94
Cash from Financing Activity
6.72
-9.94
-9.11
5.27
-13.29
-17.96
1.89
29.33
4.93
-2.50
Net Cash Inflow / Outflow
1.59
-2.74
-1.29
-0.38
5.31
-5.14
3.52
29.23
-21.16
-7.18
Opening Cash & Equivalents
1.75
4.49
5.78
6.16
-39.67
-34.53
-38.05
-67.28
-46.12
-39.01
Closing Cash & Equivalent
3.34
1.75
4.49
5.78
-34.36
-39.67
-34.53
-38.05
-67.28
-46.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
237.41
198.67
171.54
183.39
166.38
86.94
69.91
66.90
63.75
72.69
ROA
7.32%
4.86%
-4.29%
2.95%
5.29%
5.52%
1.94%
0.97%
-2.29%
-11.32%
ROE
13.09%
9.34%
-8.00%
5.42%
13.16%
22.85%
9.40%
5.00%
-11.50%
-43.27%
ROCE
15.21%
11.81%
-1.25%
8.52%
12.92%
14.69%
9.45%
9.53%
5.39%
-8.28%
Fixed Asset Turnover
1.44
1.38
1.28
1.56
1.32
1.13
1.03
1.04
0.94
0.91
Receivable days
142.49
158.78
140.57
100.75
77.33
72.04
76.05
66.90
83.91
130.33
Inventory Days
89.48
97.99
102.51
84.49
86.11
93.26
114.91
112.58
106.28
106.24
Payable days
66.44
75.58
71.78
69.42
73.88
99.57
126.74
123.69
137.24
142.68
Cash Conversion Cycle
165.53
181.20
171.29
115.83
89.56
65.73
64.22
55.79
52.95
93.89
Total Debt/Equity
0.39
0.54
0.52
0.48
0.55
1.73
2.37
2.61
3.02
2.57
Interest Cover
3.51
2.40
-0.26
1.74
2.38
2.39
1.31
1.25
0.74
-1.30

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.